Cerity Partners’s Alpha Tau Medical DRTS Stock Holding History
Bought
Maintained
Sold
Other funds holding DRTS
GIA
BFM
AF
PC
AC
AIM
Cerity Partners's DRTS Position: Q2 2026 in Review
Cerity Partners increased its Alpha Tau Medical (DRTS) stake by 27% in Q2 2026, buying an estimated $79.9K and bringing the position to 40,809 shares worth $513K. The position accounts for ﹤0.01% of the portfolio, ranked #2407.
Cerity Partners first reported a position in DRTS in Q1 2026 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.
- Cerity Partners held 40,809 shares of Alpha Tau Medical worth $513K as of Q2 2026.
- Cerity Partners bought 8,797 Alpha Tau Medical shares in Q2 2026, an estimated $79.9K.
- Alpha Tau Medical made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2407 holding.
- Cerity Partners first reported a position in Alpha Tau Medical in Q1 2026 and has held it in 2 quarters since.
- 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.
Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.